SEC Comment Letter for DarioHealth Corp. (DRIO) (CIK 0001533998) (DRIO) — May 28, 2014
DarioHealth Corp. (DRIO) (CIK 0001533998)
Date: May 28, 2014 · CIK: 0001533998 · Accession: 0000000000-14-027139
AI Filing Summary & Sentiment
Show Raw Text
May 28, 2014
Via E -mail
Erez Raphael
President and Chief Executive Officer
LabStyle Innovations Corp.
9 Halamish Street
Caesarea Industrial Park
38900, Israel
Re: LabStyle Innovations Corp.
Amendment No. 1 to Registration Statement on Form S -1
Filed May 19, 2014
File No. 333 -194710
Dear Mr. Raphael :
We have limited our review of your registration statement to those issues we have
addressed in our comments. In some of our comments, we may ask you to provide us with
information so we may better understand your disclosure.
Please respond to this letter by amending your registration statement and providing the
requested information. Where you do not believe our comments apply to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to these comments, we may have additional comments.
Form S -1 Facing Page
1. Please revise your fee table to show the number of shares currently offered for sale via
this registration statement.
Prospectus
2. We note the statement in your letter to us dated May 19, 2014 that you ha ve not entered
into any written or oral amendments or modifications to the agreements related to the
February 2014 financing. Note that generally it also would be inconsistent with Section 5
of the Securities Act to enter into negotiations regarding such amendment or modification
while the registration statement is pending. In this regard, if there are no negotiations
Erez Raphael
LabStyle Innovations Corp.
May 28, 2014
Page 2
regarding such amendment or modifications, please disclose any material failure or
inability to satisfy your obligations to the investors i n the February 2014 unregistered
offering, including your regis tration ob ligations ; quantify any related liabilities.
Results of Operations, page 26
3. Please tell us the authority on which you rely to delete the disclosure required by
Regulation S -K Item 303(a) as i t applies to your full fiscal years.
We urge all persons who are responsible for the accuracy and adequacy of the disclosure
in the filing to be certain that the filing includes the information the Securities Act of 1933 and
all applicable Securities Act rules require. Since the company and its management are in
possession of all facts relating to a company’s disclosure, they are responsible for the accuracy
and adequacy of the disclosures they have made.
Notwithstanding our comments, in the event you request acceleration of the effective date
of the pending registration statement please provide a written statement from the com pany
acknowledging that:
should the Commission or the staff, acting pursuant to delegated authority, declare the
filing effective, it does not foreclose the Commission from taking any action with respect
to the filing;
the action of the Commission or th e staff, acting pursuant to delegated authority, in
declaring the filing effective, does not relieve the company from its full responsibility for
the adequacy and accuracy of the disclosure in the filing; and
the company may not assert staff comments and the declaration of effectiveness as a
defense in any proceeding initiated by the Commission or any person under the federal
securities laws of the United States.
Please refer to Rules 460 and 461 regarding requests for acceleration. We will consider a
written request for acceleration of the effective date of the registration statement as confirmation
of the fact that those requesting acceleration are aware of their respective responsibilities under
the Securities Act of 1933 and the Securities Exchange Ac t of 1934 as they relate to the proposed
public offering of the securities specified in the above registration statement. Please allow
adequate time for us to review any amendment prior to the requested effective date of the
registration statement.
Erez Raphael
LabStyle Innovations Corp.
May 28, 2014
Page 3
Please contact Tom Jones at (202) 551 -3602 or me at (202) 551 -3617 with any questions.
Sincerely,
/s/ Russell Mancuso
Russell Mancuso
Branch Chief
cc (via e -mail): Lawrence A. Rosenbloom, Esq.